Cargando…
Epigenetic Reexpression of Hemoglobin F Using Reversible LSD1 Inhibitors: Potential Therapies for Sickle Cell Disease
[Image: see text] Sickle cell disease (SCD) is caused by a single nucleotide polymorphism on chromosome 11 in the β-globin gene. The resulting mutant hemoglobin S (HbS) is a poor oxygen transporter and causes a variety of vascular symptoms and organ failures. At birth, the DRED epigenetic complex fo...
Autores principales: | Holshouser, Steven, Cafiero, Rebecca, Robinson, Mayra, Kirkpatrick, Joy, Casero, Robert A., Hyacinth, Hyacinth I., Woster, Patrick M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315572/ https://www.ncbi.nlm.nih.gov/pubmed/32596612 http://dx.doi.org/10.1021/acsomega.0c01585 |
Ejemplares similares
-
The Role of Inflammation in The Cellular and Molecular Mechanisms of Cardiopulmonary Complications of Sickle Cell Disease
por: Gbotosho, Oluwabukola T., et al.
Publicado: (2023) -
Adhesion molecules and cerebral microvascular hemodynamic abnormalities in sickle cell disease
por: Abi Rached, Noor Mary, et al.
Publicado: (2022) -
The Role of Nutrition in Sickle Cell Disease
por: Hyacinth, H.I., et al.
Publicado: (2010) -
Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke
por: Hyacinth, Hyacinth I., et al.
Publicado: (2015) -
The injured brain might need more fat!
por: Hyacinth, Hyacinth I.
Publicado: (2018)